Article Details

Immunocore announces key appointments to management and Board

Retrieved on: 2021-02-16 12:00:00

Tags for this article:

Click the tags to see associated articles and topics

Immunocore announces key appointments to management and Board. View article details on hiswai:

Excerpt

Immunocore is a late-stage biotechnology company pioneering the development of a novel class of TCR bispecific immunotherapies called ImmTAX ...

Article found on: www.globenewswire.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up